247 related articles for article (PubMed ID: 17168782)
1. Anticancer alpha-helical peptides and structure/function relationships underpinning their interactions with tumour cell membranes.
Dennison SR; Whittaker M; Harris F; Phoenix DA
Curr Protein Pept Sci; 2006 Dec; 7(6):487-99. PubMed ID: 17168782
[TBL] [Abstract][Full Text] [Related]
2. Alpha-helical cationic anticancer peptides: a promising candidate for novel anticancer drugs.
Huang Y; Feng Q; Yan Q; Hao X; Chen Y
Mini Rev Med Chem; 2015; 15(1):73-81. PubMed ID: 25382016
[TBL] [Abstract][Full Text] [Related]
3. On the selectivity and efficacy of defense peptides with respect to cancer cells.
Harris F; Dennison SR; Singh J; Phoenix DA
Med Res Rev; 2013 Jan; 33(1):190-234. PubMed ID: 21922503
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of anticancer peptides (ACPs) from amphibian origin.
Oelkrug C; Hartke M; Schubert A
Anticancer Res; 2015 Feb; 35(2):635-43. PubMed ID: 25667440
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the secondary structure and surface activity of β-sheet forming cationic amphiphilic peptides and their anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112165. PubMed ID: 34715505
[TBL] [Abstract][Full Text] [Related]
6. Lipopeptisomes: Anticancer peptide-assembled particles for fusolytic oncotherapy.
Aronson MR; Simonson AW; Orchard LM; Llinás M; Medina SH
Acta Biomater; 2018 Oct; 80():269-277. PubMed ID: 30240951
[TBL] [Abstract][Full Text] [Related]
7. Rationally designed short cationic α-helical peptides with selective anticancer activity.
Hadianamrei R; Tomeh MA; Brown S; Wang J; Zhao X
J Colloid Interface Sci; 2022 Feb; 607(Pt 1):488-501. PubMed ID: 34509120
[TBL] [Abstract][Full Text] [Related]
8. Rational design of a new short anticancer peptide with good potential for cancer treatment.
Wu X; Tian Y; Ran K; Yao J; Wang Y; Ouyang X; Mao W; Zhang J; Li B; Yang P; Ba Z; Liu H; Gou S; Zhong C; Zhang Y; Ni J
Eur J Med Chem; 2024 Jul; 273():116519. PubMed ID: 38795519
[TBL] [Abstract][Full Text] [Related]
9. Computational Design of Biologically Active Anticancer Peptides and Their Interactions with Heterogeneous POPC/POPS Lipid Membranes.
Singh M; Kumar V; Sikka K; Thakur R; Harioudh MK; Mishra DP; Ghosh JK; Siddiqi MI
J Chem Inf Model; 2020 Jan; 60(1):332-341. PubMed ID: 31880450
[TBL] [Abstract][Full Text] [Related]
10. Mode of action of linear amphipathic alpha-helical antimicrobial peptides.
Oren Z; Shai Y
Biopolymers; 1998; 47(6):451-63. PubMed ID: 10333737
[TBL] [Abstract][Full Text] [Related]
11. CancerGram: An Effective Classifier for Differentiating Anticancer from Antimicrobial Peptides.
Burdukiewicz M; Sidorczuk K; Rafacz D; Pietluch F; Bąkała M; Słowik J; Gagat P
Pharmaceutics; 2020 Oct; 12(11):. PubMed ID: 33142753
[TBL] [Abstract][Full Text] [Related]
12. Glycan Alteration Imparts Cellular Resistance to a Membrane-Lytic Anticancer Peptide.
Ishikawa K; Medina SH; Schneider JP; Klar AJS
Cell Chem Biol; 2017 Feb; 24(2):149-158. PubMed ID: 28089756
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effect of rationally designed α-helical amphiphilic peptides.
Pan F; Li Y; Ding Y; Lv S; You R; Hadianamrei R; Tomeh MA; Zhao X
Colloids Surf B Biointerfaces; 2022 Dec; 220():112841. PubMed ID: 36174494
[TBL] [Abstract][Full Text] [Related]
14. Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment.
Mader JS; Hoskin DW
Expert Opin Investig Drugs; 2006 Aug; 15(8):933-46. PubMed ID: 16859395
[TBL] [Abstract][Full Text] [Related]
15. From a pro-apoptotic peptide to a lytic peptide: One single residue mutation.
Zhou XR; Zhang Q; Tian XB; Cao YM; Liu ZQ; Fan R; Ding XF; Zhu Z; Chen L; Luo SZ
Biochim Biophys Acta; 2016 Aug; 1858(8):1914-25. PubMed ID: 27207743
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of anticancer action and cell selectivity of short α-helical peptides.
Chen C; Hu J; Zeng P; Pan F; Yaseen M; Xu H; Lu JR
Biomaterials; 2014 Feb; 35(5):1552-61. PubMed ID: 24246647
[TBL] [Abstract][Full Text] [Related]
17. From antimicrobial to anticancer peptides. A review.
Gaspar D; Veiga AS; Castanho MA
Front Microbiol; 2013 Oct; 4():294. PubMed ID: 24101917
[TBL] [Abstract][Full Text] [Related]
18. Membrane Association Modes of Natural Anticancer Peptides: Mechanistic Details on Helicity, Orientation, and Surface Coverage.
Quemé-Peña M; Juhász T; Kohut G; Ricci M; Singh P; Szigyártó IC; Papp ZI; Fülöp L; Beke-Somfai T
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445319
[TBL] [Abstract][Full Text] [Related]
19. ACPred: A Computational Tool for the Prediction and Analysis of Anticancer Peptides.
Schaduangrat N; Nantasenamat C; Prachayasittikul V; Shoombuatong W
Molecules; 2019 May; 24(10):. PubMed ID: 31121946
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic human neutrophil peptide-1 anti-tumor activity revealed by cellular biomechanics.
Gaspar D; Freire JM; Pacheco TR; Barata JT; Castanho MA
Biochim Biophys Acta; 2015 Feb; 1853(2):308-16. PubMed ID: 25447543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
